TELO GENOMICS
Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.
TELO GENOMICS
Industry:
Biotechnology Oncology
Founded:
2011-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.telodx.com
Total Employee:
1+
Status:
Active
Contact:
416-673-8487
Email Addresses:
[email protected]
Total Funding:
6.72 M USD
Technology used in webpage:
Domain Not Resolving Amazon Font Awesome GoDaddy DNS AWS Global Accelerator
Similar Organizations
Allogene Therapeutics
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Stock Details
Official Site Inspections
http://www.telodx.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Telo Genomics"
Investors - telodx.com
The TeloView® platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability - these data are used to identify specific disease …See details»
Leadership - telodx.com
Dr. Sabine Mai, PhD Director and Chair, Clinical and Scientific Advisory Board Kenneth C. Anderson, MD Program Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics Institute Physician Kraft …See details»
Telo Genomics Completes International Standards Organization
Oct 26, 2023 Kris Weinberg, CEO 678-429-5582 [email protected] MaRS Centre, South Tower, 101 College Street, Suite 200, Toronto, ON, M5G 1L7 www.telodx.com. …See details»
Telo Genomics Completes International Standards Organization …
Oct 26, 2023 Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation Authorizes Telo to Offer its Laboratory Developed Tests ("LDT") from its …See details»
Telo Genomics Completes International Standards Organization …
Oct 26, 2023 For further information, please contact: Kris Weinberg, CEO 678-429-5582 [email protected] MaRS Centre, South Tower, 101 College Street, Suite 200, …See details»
Telo Genomics - LinkedIn
Telo Genomics | 698 followers on LinkedIn. Genomics Imaging for Precision Medicine | Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the …See details»
Telo Genomics Advances to the Final Stage of Accreditation from …
Nov 7, 2023 101 College Street, Suite 200, Toronto, ON, M5G 1L7 www.telodx.com Cautionary Note Regarding Forward-Looking Statements Certain information contained herein may …See details»
Shareholders Documents - telodx.com
MaRS Centre, South Tower, 101 College Street, Suite 200, Toronto, Ontario, Canada M5G 1L7See details»
Telo Genomics Completes International Standards Organization
Oct 26, 2023 For more information, please visit www.telodx.com. For further information, please contact: Kris Weinberg, CEO 678-429-5582 [email protected] MaRS Centre, South …See details»
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer …
Oct 17, 2023 For more information, visit www.telodx.com Kris Weinberg , CEO 678-429-5582 [email protected] MaRS Centre, South Tower , 101 College Street , Suite 200, …See details»
Telo Genomics Launches Physician Experience Program in the …
Nov 16, 2023 SMART Observational Study a Critical Step Toward Full Platform Availability Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Telo Genomics Corp. (TSXV: TELO) …See details»
Publications - telodx.com
Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma. Genes, Chromosomes & …See details»
Telo Genomics Completes International Standards Organization …
Oct 26, 2023 Detailed price information for Telo Genomics Corp (TELO-X) from The Globe and Mail including charting and trades.See details»
Telo Genomics Achieves Noteworthy International Standards …
Sep 6, 2023 For more information, please visit www.telodx.com. For further information, please contact: Kris Weinberg, CEO 678-429-5582 [email protected] MaRS Centre, South …See details»
Telo Genomics' Multiple Myeloma Drug Resistance Study Results …
May 4, 2023 Telo's lead product is designed to identify high-risk SMM patients who may receive earlier treatment intervention before the patient develops symptoms from active MM. Notably, …See details»
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi …
Aug 14, 2023 For more information please visit www.telodx.com. For further information, please contact: Sherif Louis, President & CTO Telo Genomics 416-673-8487 www.telodx.com.See details»
TeloView - telodx.com
Distinct nuclear organization of telomeres and centromeres in monoclonal gammopathy of undetermined significance and myeloma. Yu PLI & Mai S et al. Cells 8, 723, 2019. Inhibition …See details»
Telomere Science - telodx.com
“Telomeres dysfunction” is commonly seen in cancer cells where critically short telomeres do not trigger cell death. Moreover, telomere dysfunction is characterized by an altered 3D …See details»
Telo Genomics Gears up for American Society of Hematology …
Dec 6, 2023 ON, M5G 1L7 www.telodx.com Cautionary Note Regarding Forward-Looking Statements Certain information contained herein may constitute "forward-looking information" …See details»